Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants Nürnberg, July 31, 2023 – Bio-Gate AG (ISIN DE000BGAG981), one of the …
WeiterlesenBio-Gate strengthens presence in the North American market for innovative animal care Bio-Gate’s customer launches a new product line for ear infections Technological leadership in …
WeiterlesenBio-Gate concludes another cooperation agreement with leading multinational implant manufacturer Medical technology business further strengthenedMedical technology business further strengthened Coating of orthopaedic revision implants with …
WeiterlesenBio-Gate and Avicanna complete first phase of development on Cannabidiol and Micro Silver BG™ based skin care products for global commercialization Entry into another growth …
WeiterlesenBio-Gate expands customer base for antiviral and antibacterial products MSBG-Tec protective film spray from Bio-Gate complements hygiene strategies in public spaces Antiviral mask hygiene spray …
WeiterlesenBio-Gate successfully markets antiviral and antibacterial Protective Film Spray for surfaces Protective Film Spray from Bio-Gate used for the first time in public transport in …
WeiterlesenBio-Gate signs cooperation agreement with Aesculap AG for coating revision implants HyProtectTM-Focus on the antimicrobial coating of revision implants for knee and hip care in …
WeiterlesenBio-Gate AG: Screening test proves effectiveness of various MicroSilver BG™ products against viruses Tested products are already available on the market Additional new products with …
WeiterlesenWe are represented at the following shows and events: MedTecLive – May 21 – 23, 2019 in Nuremberg in-cosmetics – April 02 – 04, 2019 …
Weiterlesen